Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care

scientific article published on 25 June 2016

Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.BPG.2016.06.003
P698PubMed publication ID27644908

P2093author name stringAlejandra Méndez Romero
Robert A de Man
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectadaptive radiation therapyQ180507
P304page(s)603-616
P577publication date2016-06-25
P1433published inBest Practice and Research: Clinical GastroenterologyQ15754316
P1476titleStereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care
P478volume30

Reverse relations

cites work (P2860)
Q58793629Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis
Q49599453Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors
Q57800089Repeated SBRT for in- and out-of-field recurrences in the liver
Q64094411Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases
Q61054484Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
Q47137682Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Q56960702Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis - Authors' reply
Q48265633The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy

Search more.